Yet, contrary to our expectations and challenging a common hypothesis in the field [17,29], we found that maternal plasma VL magnitude and kinetics were not significantly different between AF-positive and AF-negative immunocompetent dams. The gene discussed is MLC1; the disease is atrial fibrillation.